Hexagon Nutrition Ltd. Share Price

Overview

Hexagon Nutrition Ltd. share price is currently ₹67.89, up by ₹4.12 (6.46%) from its previous closing price of ₹63.77. The share price has gained 2.51% over the past month and gained 5.35% over the past year. The stock's 52-week low and high are ₹47.41 and ₹77.38, respectively. Hexagon Nutrition Ltd. has a market capitalisation of ₹ 800.00 Cr. The share price was last updated on 30 Sep 2026, 03:55 PM IST.

Hexagon Nutrition Ltd.
Hexagon Nutrition Ltd.
HEXAGON
 ₹0.00
 ₹4.12
6.46%
Healthcare
 ₹0.00(%)1D

Updated: 30 Sep 2026, 03:55:04 pm IST

Market Data

Open Price

 ₹64.44

Prev. Close

 ₹63.77
 ₹63.84

Day Low

 ₹67.91

Day High

 ₹47.41

52 Week Low

 ₹77.38

52 Week High

HealthcarePharmaceuticals & Drugs
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

30.86

Sector PE

45.00

PB Ratio

4.13

Sector PB

5.98

EPS

2.20

Dividend Yield

0.00

Today's Volume

980.810 K

5 Day Avg. Volume

264.007 K

PEG Ratio

0.31

Market Cap.

₹ 800.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 30% at ₹0.3/Share
15-Sep-202615-Sep-2026

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
Bandhan Small Cap Fund - Regular Plan - Growth24.97 Lac
24.67 Lac
(1.2%)

About Hexagon Nutrition Ltd. 👋

Hexagon Nutrition Limited is an India-based research-oriented pure play nutrition company. The Company is engaged in the manufacturing and trading of nutraceuticals clinical or dietary supplements, micronutrient premixes and animal feed. Its product portfolio is classified into three segments: Branded nutrition products/ clinical nutrition products (B2C segment), Premix formulations (B2B2C segment), and Ready to use foods (RUFs) and Micro Nutrient Powder (MNPs) (ESG segment). The B2C segment offers branded wellness and clinical nutrition products encompassing daily nutritional requirements across demographics from pediatric to geriatric nutrition. Its B2B2C segment offers customized micronutrient formulation in the form of vitamin and mineral premixes that are supplied to Indian and multi-national fast-moving consumer goods players for fortification of consumer products. The ESG segment offers therapeutic foods in two forms: nutrient-dense RUFs in paste form and Micronutrient Powders.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Prameela Balakkala

Prameela Balakkala

13 Aug • 10:46 AM · SEBI-Registered Analyst

Hexagon Nutrition Q1 FY26: Profit Growth, Revenue Surge, Margin Pressure

HEXAGON
📊 Q1 FY26 Financial Snapshot Net Profit: ₹807M vs ₹645M (YoY +25%). Revenue: ₹1B vs ₹728M (YoY +38%). EBITDA: ₹117M vs ₹100M (YoY +17%). EBITDA Margin: 11.24% vs 13.83% (YoY decline due to cost pressures). 📌 Fundamentals & Ratios Debt-to-Equity: ~0.3, low leverage and strong balance sheet. P/E Ratio: ~22–24, reflecting growth expectations in the nutrition sector. ROE: ~13–14%, healthy return on equity. EBITDA Margin: 11.24%, slightly compressed YoY. Dividend Yield: ~0.8%, modest shareholder payout. 🥗 Key Projects & Business Drivers Micronutrient Fortification: Expanding fortified foods and supplements. Clinical Nutrition: Growth in medical-grade nutrition products. Exports: Expanding footprint in Asia and Africa. R&D: Focus on innovative formulations in health and wellness. Strategic Partnerships: Collaborations with healthcare providers and NGOs. ⚠️ Risks & Watchpoints Margin Pressure: Rising raw material and input costs. Regulatory Risks: Compliance with food safety and health regulations. Global Demand Cyclicality: Dependent on consumer health trends. Competition: Intense rivalry in nutrition and supplements. Execution Risks: Scaling up new product lines efficiently

See More
AASHISH RA

AASHISH RA

5 Jul • 11:13 PM · SEBI-Registered Analyst

Hexagon Nutrition Ltd. – SWOT Analysis

HEXAGON
Strengths (S) Research-driven business with expertise in micronutrient premixes, clinical nutrition, and food fortification products. Diversified product portfolio serving pharmaceutical, food, healthcare, and wellness industries. Presence in multiple international markets, providing geographical revenue diversification. Healthy profitability with improving operating performance, supported by ROCE above 20% and consistent earnings growth. confidence. Weaknesses (W) Business depends significantly on a limited number of institutional and export customers. Working capital cycle has increased, leading to higher capital requirements. Return on Equity, while healthy, remains lower than some leading nutrition and healthcare peers over the longer term. Margins can be affected by fluctuations in prices of imported vitamins, minerals, and other raw materials. Being a relatively small-cap company, it has lower bargaining power than larger multinational nutrition companies. Opportunities (O) Rising demand for nutritional supplements, preventive healthcare, and fortified foods in India and overseas. Government initiatives addressing malnutrition and food fortification can support long-term growth. Expansion into clinical nutrition, sports nutrition, and wellness products offers higher-margin opportunities. Increasing export demand from developing countries for micronutrient solutions. Growing institutional participation may improve liquidity and valuation over time. Threats (T) Intense competition from domestic and global nutrition and healthcare companies. Volatility in imported raw material prices and foreign exchange rates may pressure margins. Regulatory changes in food safety and pharmaceutical standards could increase compliance costs. Global economic slowdowns may reduce export demand. Customer concentration risk may affect revenues if key clients reduce orders.

See More
Vipin Dixena

Vipin Dixena

14 Jun • 11:06 PM · SEBI-Registered Analyst

Can

HEXAGON
Market Debut Signal the Next Opportunity in India’s Nutrition Story?

HEXAGON
made a solid stock market debut, listing at a premium of over 7% against its IPO price of Rs 45. The Rs 139 crore IPO attracted strong investor interest, with subscriptions reaching 53.68 times, reflecting confidence in the company’s nutrition-focused business model. Founded in 1993, Hexagon Nutrition develops micronutrient premixes, clinical nutrition products, and wellness solutions, exporting to over 75 countries. The company has also delivered strong financial growth, with FY25 profit nearly doubling year-on-year. As health awareness and preventive nutrition gain traction in India, Hexagon’s successful debut could highlight the growing investment potential of the nutrition and wellness sector.

See More
Prameela Balakkala

Prameela Balakkala

12 Jun • 8:38 AM · SEBI-Registered Analyst

Indian Markets Poised for a Robust Start Amid Global Calm and Crude Relief

A strong opening for Indian markets today, driven by easing US–Iran tensions and crude oil dipping below $90 per barrel. 🌍 Global Market Momentum ✅ US indices surged on June 11 — Dow up 1.86% at 50,849, S&P 500 rose 1.75% to 7,394, Nasdaq climbed 2.54% to 25,810. ✅ Asian markets rally sharply with Nikkei +3.4%, Kospi +7%, and Hang Seng futures trending higher. ✅ Commodities eased — Brent crude at $89.17 (-1.3%), WTI $86.48 (-1.4%), while gold holds steady near ₹4,189/oz. Indian Market Snapshot 📈 Sensex closed June 11 at 73,833, down 151 points (-0.20%). 📈 Nifty 50 ended at 23,162, slipping 53 points (-0.23%). 📈 GIFT Nifty futures signal a gap-up start around 23,450, up nearly 200 points. 🔑 Key Drivers - Positive global cues from reduced geopolitical risks and cooling crude prices. - RBI’s recent hawkish pause with repo at 5.25%, GDP forecast trimmed to 6.6%, and inflation raised to 5.1% remains a medium-term consideration. 💰 FII & DII Flows (June 11) ⚡ FIIs were net sellers at ₹1,987 crore, primarily offloading positions in IT, metals, and PSU banks. ⚡ DIIs stepped in as net buyers with ₹4,225 crore, supporting banking, FMCG, and auto sectors. 🏢 Corporate Highlights for June 12 📊 Results from Omkar Speciality Chemicals, SIC Ltd, Vegorama Punjabi Angithi, and VPAL.

RELIANCE
📊 Stocks to watch: - Reliance Industries advancing AI capabilities through Meta partnership. - Sagility’s $30M acquisition in the US market. - Vedanta’s demerger entities slated for listing on June 15. - Hexagon Nutrition’s IPO debut today. - Kotak Mahindra Bank receives positive brokerage outlook. - Torrent Pharma benefiting from pharma sector momentum. - Grasim Industries accelerating capex expansion plans. 📊 Options Sentiment: Nifty PCR at ~0.92 🔍 Indicates a neutral to slightly bearish stance with support levels near 23,050–23,100 and resistance at 23,300–23,350.

See More
Covesting Technologies Pvt Ltd

Covesting Technologies Pvt Ltd

10 Jun • 9:11 AM · SEBI-Registered Analyst

Important pre-market news today! - 🌍 Geopolitical Impact on Markets US-Iran tensions weigh on Nifty, Sensex; global risk-off sentiment affects equities and crude oil. - 🛢️ Crude Oil Volatility Brent nears $92 post-US strikes; demand concerns from China keep prices volatile around $89-$92 range. - 📈 Capital Small Finance Bank Stake Lyptus Punch-Card Fund acquires stake amid stock’s 7.5% drop last month and mixed longer-term trends. - 💊 Pharma & Defence Focus Nuvalent jumps 39% on GSK buyout; Defence stocks HAL, BEL highlighted for strong growth and orders. - 📊 Market Sentiment & IPOs NLC India OFS oversubscribed 5.2x; Hexagon Nutrition IPO 53x subscribed; contrarian opportunities in large/mid-caps noted.

See More
Ketan Mittal (SEBI RA)

Ketan Mittal (SEBI RA)

7 Jun • 9:36 PM · SEBI-Registered Analyst

Hexagon Nutrition IPO

The Hexagon Nutrition IPO received a strong response from investors on the opening day of bidding, with the issue getting fully subscribed within hours of launch. The ₹139-crore public issue attracted bids for 3.55 crore shares against 2.16 crore shares on offer, resulting in an overall subscription of 1.65 times, according to NSE data. The retail investor portion was subscribed 2.42 times, while the non-institutional investor (NII) category was booked 2.03 times. The Qualified Institutional Buyers (QIB) segment, however, did not receive bids on the first day. The Hexagon Nutrition IPO date is June 5-9, 2026, with the issue closing for subscription on 9 June. Shares of the company are expected to be listed on the stock exchanges on June 12, 2026.

See More

News & Events

Frequently Asked Questions

What is the share price of Hexagon Nutrition Ltd.?

What is the market cap of Hexagon Nutrition Ltd.?

Should I buy Hexagon Nutrition Ltd. stock now?

What is the 52 week high and low of Hexagon Nutrition Ltd.?

Is the Hexagon Nutrition Ltd. stock good to buy?

Is Hexagon Nutrition Ltd. a good buy for the long term?

Is Hexagon Nutrition Ltd. overvalued or undervalued?

What is the PE and PB ratio of Hexagon Nutrition Ltd.?

Start Now